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dietary intervention for primary prevention in
primary care: population-based cohort study and
Markov model
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Abstract
Background: A healthy diet is associated with reduced risk of diabetes, cardiovascular disease and cancer. The
study aimed to evaluate the cost-effectiveness of a universal strategy to promote healthy diet through brief
intervention in primary care.
Methods: The research was informed by a systematic review of randomised trials which found that brief
interventions in primary care may be associated with a 0.5 portion per day increase in fruit and vegetable
consumption. A Markov model that included five long-term conditions (diabetes, coronary heart disease, stroke,
colorectal cancer and depression) was developed. Empirical data from a large cohort of United Kingdom-based
participants sampled from the Clinical Practice Research Datalink populated the model. Simulations compared an
intervention promoting healthy diet over 5 years in healthy adults, and standard care in which there was no
intervention. The annual cost of intervention, in the base case, was one family practice consultation per participant
year. Health service costs were included and the model adopted a lifetime perspective. The primary outcome was
net health benefit in quality adjusted life years (QALYs).
Results: A cohort of 262,704 healthy participants entered the model. Intervention was associated with an increase
in life years lived free from physical disease of 41.9 (95% confidence interval -17.4 to 101.0) per 1,000 participants
entering the model (probability of increase 88.0%). New incidences of disease states were reduced by 28.4 (18.7 to
75.8) per 1,000, probability reduced 84.6%. Discounted incremental QALYs were 4.3 (-8.8 to 18.0) per 1,000, while
incremental costs were £139,755 (£60,466 to 220,059) per 1,000. Net health benefits at £30,000 per QALY were -0.32
(-13.8 to 13.5) QALYs per 1,000 participants (probability cost-effective 47.9%). When the intervention was restricted
to adults aged 50 to 74 years, net health benefits were 2.94 (-21.3 to 26.4) QALYs per 1000, probability increased
59.0%.
Conclusions: A universal strategy to promote healthy diet through brief intervention in primary care is unlikely to
be cost-effective, even when delivered at low unit cost. A targeted strategy aimed at older individuals at higher risk
of disease might be more cost-effective. More effective dietary change interventions are needed.
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Background
Diet is an important determinant of health [1]. Dietary
intakes are associated with the risk of chronic diseases
including diabetes, cardiovascular diseases and cancer
[2]. Dietary risk factors, including low consumption of
fruit and vegetables, together with physical inactivity,
account for about 10% of the total global burden of dis-
ease [1]. Dietary exposures are important across the life-
course and present dietary habits may determine the
development of chronic diseases in later life [3]. It is
estimated that a long term increase in intake of fruit and
vegetables of one portion per day (80 g/day) might be
associated with a 10% relative reduction in risk of
ischaemic heart disease and 6% reduction in stroke, with
between 1% and 6% reduction in risk of certain cancers
[4]. National recommendations advocate increasing the
consumption of a variety of fruit and vegetables each
day in order to reduce risks of obesity, diabetes, cardio-
vascular disease and certain cancers [5].
The regularity of patient consultations, and the value
patients place on primary care advice, offer primary care
clinicians an opportunity to promote healthy lifestyles,
including dietary change [6]. A number of randomised
trials have evaluated the effectiveness of dietary inter-
ventions for primary prevention in primary care [7-16].
These have shown small beneficial effects on dietary in-
takes including consumption of fruits, vegetables, fibre,
fat and on serum cholesterol, with benefits maintained
over a period of up to one year. However, in a meta-
analysis of trials in primary care settings, we found that
the mean increment in fruit and vegetable consumption
associated with brief interventions in primary care
amounted to about 0.5 (95% confidence interval 0.13 to
0.87) portions per participant per day [17]. This is
consistent with the findings of Rees et al. [18], which in-
cluded a wider range of intervention settings and partici-
pants in their review. An increase in fruit and vegetable
consumption of this magnitude might yield worthwhile
health benefits, if it were to be maintained over long
enough periods of time or in a large enough population.
However, primary research studies of sufficient scale and
duration have not yet been implemented.
The present research used a Markov simulation model
to evaluate the potential long-term outcomes and costs
of a universal strategy to promote healthy diet through
brief intervention in primary care. The research speci-
fically aimed to evaluate the cost-effectiveness of a uni-
versal strategy of brief dietary intervention for primary
prevention in primary care. The target population for
the research was the general population of healthy
adults, free from chronic disease, registered in primary
care. We compared a strategy of brief intervention
to promote healthy diet delivered to all healthy adults,
focusing on increasing consumption of fruit and
vegetables, with ‘standard care’ in which there is no sys-
tematic approach to dietary intervention.
Methods
We utilised a similar methodological approach to one
reported previously to evaluate brief interventions to
promote physical activity [19].
Overview and Markov model
A Markov model was designed drawing on previously
reported research [20]. Participants entering the model
were aged 30 years and over because of the low risk of
chronic disease at younger ages. Healthy participants
free from chronic disease, referred to as At Risk, could
develop one of the disease states of interest including
Diabetes mellitus, Coronary Heart Disease, Stroke or
Colorectal cancer. Participants were allowed to progress
to multiple disease states, representing all potential com-
binations of the selected conditions, consistent with the
frequent development of multiple morbidity in primary
care [21]. Participants in each state were allowed to pro-
gress to Depression, or to remain Not Depressed [22].
Depression was included in the Model because the
prevalence of depression is increased in many chronic
diseases and depression is associated with higher health
care costs [22]. Depression was considered to be rever-
sible; in each cycle participants transitioned to Depres-
sion on a probabilistic basis, based on the prevalence of
depression observed in that state. All model states might
progress to death. The model included a total of 32
states, representing the potential combinations of in-
cluded diseases and depression. A schematic diagram of
the model was previously reported [19]. The cost ana-
lysis was from the health care perspective and only costs
of health care utilisation were included. A life time hori-
zon was used for the analysis. The model was stratified
by gender and single year of age.
CPRD cohort and empirical inputs to the model
The model was populated with empirical estimates
drawn from a large cohort of participants registered with
family practices participating in the UK Clinical Practice
Research Datalink (CPRD), previously known as the
General Practice Research Database (GPRD). Partici-
pants were sampled from family practices continuously
contributing data to the CPRD between 1 January 2004
and 30 October 2010. Participants comprised a random
sample of 299,912 registered patients, aged 30 to
100 years. CPRD data were analysed to estimate, for
each state in the model, the incidence of the state, the
mortality in each state, the prevalence of depression, and
the costs of health care utilisation. Estimates were ob-
tained by 10-year age group and sex. The methodo-
logical approach to analysis has been reported previously
Gulliford et al. Cost Effectiveness and Resource Allocation 2014, 12:4 Page 2 of 9
http://www.resource-allocation.com/content/12/1/4
[22]. Unit costs of health care utilisation were obtained
from standard reference sources for 2010 [23]. The Mul-
tilex drug code for each prescription record in CPRD
was linked to unit costs in the First DataBank Europe
database in order to obtain prescription costs [24]. The
empirical mean and standard deviation for costs asso-
ciated with each participant was estimated according to
10-year age group, sex and model state. Utilities for each
state were obtained from data published in a compen-
dium of values [25]. Utility values for each state were
stratified by single year of age but were the same for
men and women.
Model estimates
The Markov model, with probabilistic cohort simula-
tion, was programmed using R software [26]. Out-
comes and costs were compared for Intervention and
Standard Care over 70 annual cycles, this allowed the
entire cohort to progress either to death or to reach
age 100 and exit the model. Annual transition prob-
abilities for the model were obtained by sampling
from the beta-binomial distribution, using CPRD data
as inputs. Utility values were sampled from the beta
distribution. The costs of each state were sampled
from the gamma distribution with the mean value
from CPRD, by10-year age group, sex, condition and
depression status, as the empirical input. The model
was implemented with a half cycle correction for the
estimation of QALYs and costs.
Total costs and quality adjusted life years (QALYs) were
obtained by summing across the 70 cycles of the model
included in each simulation. There were 2,000 simulations
run for each of intervention or standard care scenarios.
Results are expressed as rates per 1,000 healthy partici-
pants entering the model. Mean costs, and the 95% range,
were obtained from the data for 2,000 simulations. Incre-
mental costs and QALYs were obtained as the difference
between intervention and standard care scenarios. Costs
and QALYs were discounted using a rate of 3.5%, but
QALYs were also discounted at a rate of 1.5% as a sen-
sitivity analysis. Not all simulations were associated with
positive incremental costs and QALYs, making the incre-
mental cost-effectiveness ratio a less suitable measure for
analysis [27]. Net health benefits (NHB), at a threshold
value of £30,000 per QALY, were therefore calculated as
the difference between the increment in QALYs and the
increment in costs divided by the threshold value of cost
per QALY [28]. (pages 128-130) A cost-effectiveness ac-
ceptability curve was plotted using a range of threshold
values.
Intervention effects and costs
The intervention was assumed to modify only the
incidence of physical disease in healthy participants at
risk. Changes in occurrence of multi-disease states,
prevalence of depression and mortality were assumed to
be secondary to changes in the incidence of diabetes,
coronary heart disease, stroke and colorectal cancer.
Relative risks of diabetes, coronary heart disease, stroke
and colorectal cancer, associated with fruit and vegetable
consumption were calculated using two sources of infor-
mation. The first was a systematic review of randomised
trials in primary care [17] that provided an estimated 0.5
(95% confidence interval 0.13 to 0.87) portion per day
increment in fruit and vegetable consumption from brief
dietary intervention in primary care. This was combined
with estimated age-specific relative risks of disease out-
comes associated with dietary change derived from the
World Health Organization report. (Table 9.28, page
696). The intervention and the intervention effect were
modelled to be maintained for five years. In the absence
of evidence for the time course of intervention effects, a
constant intervention effect was modelled in each of the
first five cycles of the model. The cost of the interven-
tion was modelled as a fixed cost per person per year
and was assumed initially to be equivalent as the cost of
one family practice consultation. Sensitivity analyses was
carried out taking costs of intervention equivalent to
two family practice consultations per year and 20% of a
single family practice consultation per year. In secondary
analyses, the effect of intervention was also modelled in
selected age groups to allow the comparison of cost-
effectiveness between age groups. There were 1,000
simulations performed in each age group because of the
greater computational burden.
Consent
We used anonymous data approved by CPRD without
identifying the patient and written informed consent was
not required from the patients for the publication of
this paper and any accompanying images.
Results
Table 1 presents the estimated relative risk values for
intervention effects on incidence of study conditions.
The figures are mean and range of values for 2,000
Table 1 Summary of the modelled effect of intervention
on incidence of study conditions
Disease condition Effect of intervention (Relative risk)
Male Female
Diabetes mellitus 0.965 (0.961 to 0.968) 0.964 (0.961 to 0.968)
Coronary heart disease 0.959 (0.955 to 0.963) 0.959 (0.955 to 0.963)
Stroke 0.975 (0.972 to 0.978) 0.975 (0.972 to 0.978)
Colorectal cancer 0.997 (0.995 to 0.998) 0.997 (0.995 to 0.998)
Figures represent the mean relative risk value (95% interval) for 2,000
simulations, based on the mean values across all ages in the first cycle.
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simulations based on the mean values across all ages in
the first cycle of each simulation. An intervention effect
of 0.95 indicates a 5% lower incidence rate compared to
incidence rate with no intervention. In general, interven-
tion was associated with relative risk reductions of 4% or
smaller, when averaged across all age groups.
There were 262,704 healthy participants, based on the
age distribution of healthy participants aged 30 years
and older in CPRD, who entered the model in each
simulation (Table 2). There were 129,396 men (mean
age 51 years) and 133,308 women (mean age 54 years).
Crude incidence rates from the Model under standard
care for the age range 30 to 100 years were diabetes 6.5
per 1,000, coronary heart disease 7.6 per 1,000, stroke
4.1 per 1,000 and colorectal cancer 1.0 per 1,000, con-
sistent with empirical values previously reported from
analysis of CPRD [29-31]. Following intervention, with
the intervention effect continuing for 5 years, there was
an increase in life years lived without physical disease of
41.9 (-17.4 to 101.0) per 1,000 participants entering the
model. There was 88% probability that life years free
from physical disease were increased. There was a mod-
est reduction in new occurrences of diabetes mellitus
and coronary heart disease amounting to about 0.5 cases
per 1,000 participants entering the model but there was
negligible change in new occurrences of stroke and colo-
rectal cancer. Over the course of the model, the number
of life years lived with a single physical morbidity was
reduced by 28.4 life years per 1,000 participants entering
the model, with the probability of reduction of 84.6%.
There was some evidence of a reduction in life years
with dual morbidities but negligible effect on triple or
quadruple morbidities. There was weak evidence of a re-
duction in overall life years lived with depression, which
was consequent on the reduction in morbidity as there
was no modelled direct effect of intervention on depres-
sion prevalence.
The mean discounted incremental costs associated with
intervention were £139,755 per 1,000 participants entering
the model (Table 2). The mean cost associated with inter-
vention was £153,521 per 1,000 but this was offset by a
small decrease in the costs of non-intervention health care
Table 2 Health outcomes and cost-effectiveness of a healthy eating intervention in a population of 262,704 healthy
participants
Difference Probability
(Intervention-standard care) (%)
Number entering intervention 262,704
Life years lived without disease (per 1,000)a 41.9 (-17.4 to 101.0) 88.0
New incidences per 1,000 of:
Diabetes mellitus -0.5 (-2.2 to 1.23) 67.7
Coronary heart disease -0.6 (-2.4 to 1.3) 69.0
Stroke 0.02 (-1.5 to 1.6) 49.7
Colorectal cancer 0.04 (-0.7 to 0.8) 46.2
Life years lived with physical morbidity (per 1,000)a
Single condition -28.4 (-75.8 to 18.7) 84.6
Dual conditions -7.2 (-28.9 to 14.4) 71.0
Triple conditions -0.7 (-7.5 to 6.1) 56.1
Quadruple conditions -0.0 (-1.4 to 1.5) 52.2
Life years lived with depression (per 1,000)a -2.9 (-16.6 to 11.2) 63.9
Total life years (per 1,000)a 5.7 (-36.6 to 47.3) 41.1
Total intervention costs (£ per 1,000) 153,521 (153,462 to 153,583) 100.0
Incremental costs of non-intervention health care utilisation (£ per 1,000) -13,765 (-93,093 to 66,556) 38.8
Incremental total costs (£ per 1,000)a,b 139,755 (60,466 to 220,059) 99.8
Incremental QALYs (discounted 3.5%) (per 1,000) 4.3 (-8.8 to 18.0) 68.8
Incremental QALYs (discounted 1.5%) (per 1,000) 6.3 (-15.6 to 28.4) 67.0
Net health benefits (QALYs per 1,000)b,c -0.32 (-13.8 to 13.5) 47.9
Probability cost effective 47.9
At £30,000 per QALY (%)
aper 1,000 healthy participants entering model; bdiscounted at 3.5%; cnet health benefit at a threshold of £30,000 per QALY.
Figures represent mean and 95% range of 2,000 simulations.
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utilisation amounting to -£13,765 per 1,000. The mean
discounted incremental QALYs associated with interven-
tion were 4.3 per 1,000 participants entering the model.
At a threshold of £30,000 per QALY, the mean net health
benefit was -0.32 QALYs per 1,000 participants. The pro-
bability of intervention being cost effective at cost effect-
iveness threshold of £30,000 per QALY was 47.9%.
Sensitivity analyses were carried out to explore the ef-
fects of varying the discount rate, varying the unit costs
of the intervention and varying the age group targeted
for intervention. When QALYs were discounted at 1.5%,
the mean increment associated with intervention was
6.3 QALYs per 1,000 (Table 2). The mean net benefits at
a threshold of £30,000 per QALY were then 1.7 per
1,000, with a probability cost-effective of 54.5%. As
expected, the effect of increasing the unit costs of inter-
vention costs was to lower the estimated cost effective-
ness (Table 3). If the unit cost of intervention amounted
to two family practice consultations per year then mean
net health benefits were negative (-5.4, 95% CI -18.9 to
8.4) with the probability of the intervention being cost-
effective was 26%. If the cost of the intervention was
equivalent to 20% of cost of one family practice con-
sultations per year, equivalent to two minutes out of a
10 minute consultation, then the net health benefit was
3.8 (-9.7 to 17.6) QALYs per 1000, with a probability
cost-effective of 66.7%.
Table 4 and Figure 1 present estimates for the cost
effectiveness of a brief dietary intervention in primary
care when delivered only to selected age groups. The ef-
fect of intervention on fruit and vegetable consumption
was assumed to be independent of age, but changes in
disease risk from dietary change were age-dependent [3].
Net health benefits at a threshold of £30,000 per QALY
were lowest when a universal policy targeting all adults
aged greater than 30 years was employed. As the lower
age limit for eligibility for intervention was raised, first
to 40 years and then to 50 years, then gain in QALYs
associated with intervention increased, while the
incremental costs per 1,000 participants showed little
change. Consequently, net health benefits were higher
when the lower age limit for intervention was 50 years,
than when intervention included all those over 30 years.
The effect of reducing the upper age limit for interven-
tion to 74 years, generally had a more limited impact on
the estimated cost-effectiveness of intervention. Even in
the most favourable scenario, where the eligibility for
intervention was restricted to the age range 50 to
74 years, the probability of the intervention being cost-
effective was less than 60% at a threshold of £30,000 per
QALY, with little impact from increasing the threshold
value (Figure 1).
Discussion
What this study shows
Our study modelled the health outcomes of a universal
strategy for brief intervention to promote dietary change
in primary care. We used a very large empirical popula-
tion registered in UK primary care practices to represent
the study population. The intervention effect was
derived from a meta-analysis of randomised controlled
trials with at least 12 months follow up. The results sug-
gest that even with a very small intervention effect, such
as an increase in fruit and vegetable consumption of half
a portion per day, when maintained over prolonged pe-
riods of time might bring appreciable benefits in terms
of number of years lived free from chronic disease. How-
ever, even when delivered at very low cost, we estimate
that a universal intervention strategy is unlikely to prove
cost-effective. We initially considered the possibility that
the intervention could be delivered through resource use
equivalent to one family practice consultation per year.
However, our systematic review revealed that interven-
tion strategies are generally more costly than this, re-
quiring multiple face to face visits, singly or in groups,
together with supporting written materials and follow-
up communications. An effective intervention may be
more costly and even less cost-effective that we have
Table 3 Effect of varying the unit cost of intervention
Annual unit cost of intervention
0.2 GP consultations per year
(£7 per participant year)
Cost equivalent to one GP consultation
per year (£35 per participant year)
Cost equivalent to two GP consultations
per year (£70 per participant year)
Incremental QALYsa 4.3 (-8.8 to 18.0) 4.3 (-8.8 to 18.0) 4.3 (-8.8 to 18.0)
Incremental costa 16,939 139,755 293,276
(-62,385 to 97,256) (60,446 to 220,059) (213,985 to 373,563)
Net health benefita,b 3.8 -0.32 -5.4
(-9.7 to 17.6) (-13.8 to 13.5) (-18.9 to 8.4)
Probability cost-effective 66.7 47.9 25.6
adiscounted at 3.5%; bnet health benefit at a threshold of £30,000 per QALY.
Figures are expressed per 1,000 participants entering the model and represent mean and 95% range of 2,000 simulations.
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estimated. Our analysis suggests that a targeted strategy
focusing on older individuals who may be at higher risk
of disease may be a more appropriate strategy for imple-
mentation in primary care. However, more research is
needed to explore the optimal strategy for targeting
intervention. The results also serve to emphasise the im-
portance of developing more effective interventions to
promote dietary behaviour change.
What other study show
Our conclusions are consistent with those of Cobiac
et al. [32] who reviewed published literature and mo-
delled the evidence available from range of 23 interven-
tions for promoting fruit and vegetable consumption in
adults. Their study concluded that interventions directed
at individuals and relying on dietary counselling, tele-
phone contact, worksite promotion and other methods
which encourage dietary behaviour change are neither
highly effective nor cost effective. Pomerlau et al. [33]
also found that dietary change interventions generally
had small effects, with larger effect sizes observed in se-
condary prevention studies. This is also consistent with
the suggestion that a targeted intervention strategy may
be more appropriate in primary care.
Strengths and limitation of this study
This study was informed by the results of a new syste-
matic review that was tailored to the objective of this
Table 4 Cost-effectiveness of dietary intervention in selected age-groups
Age group Life years healthy Incremental QALYsa Incremental Costsa Net health benefitb Probability cost-effective (%)
30 years and over 44.1 4.40 140,716 -0.29 48.5
(-21.0 to 105.7) (-10.0 to 18.6) (63,609 to 217,580) (-14.5 to 13.6)
30 to 74 years 42.1 3.84 140,758 -0.85 47.5
(-23.3 to 107.0) (-11.2 to 19.1) (59,557 to 221,842) (-16.4 to 14.1)
40 years and over 49.7 5.3 131,152 0.95 52.8
(-15.8 to 117.6) (-10.3 to 22.2) (53,690 to 206,149) (-14.8 to 17.2)
40 to 74 years 51.9 5.7 136,606 1.12 54.2
(-16.3 to 127.7) (-11.2 to 22.4) (56,301 to 215,257) (-16.0 to 17.8)
50 years and over 55.6 6.8 131,812 2.41 56.0
(-11.7 to 126.5) (-14.6 to 28.9) (60,978 to 208,546) (-18.6 to 24.6)
50 to 74 years 61.5 7.4 132,929 2.94 59.0
(-21.0 to 146.2) (-16.7 to 31.9) (56,612 to 205,664) (-21.3 to 26.4)
adiscounted at 3.5%; bnet health benefit at a threshold of £30,000 per QALY.
Figures are expressed per 1,000 participants entering the model and represent the mean and 95% range of 1,000 simulations in each age group.
Figure 1 Cost-effectiveness acceptability curves for dietary intervention targeted at selected age groups.
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research. The model was informed by analysis of a sam-
ple of nearly 300,000 participants sampled from the
CPRD which is grounded in a general population sample
of nearly six million people in the UK. The modelling
approach was fully probabilistic which meant that uncer-
tainties in the model inputs were carried through into
uncertainties in the model outputs. This was necessary be-
cause estimates for incidence and mortality were impre-
cise for less frequent conditions. We implemented a series
of sensitivity analyses that explored the effect of varying
key assumptions. We acknowledge that we modelled an
intervention duration (five years) that is longer than has
been implemented in randomised trials (one year). How-
ever, it appears unlikely that a behavioural intervention
could be more effective over a longer period than a
shorter period, so this does not vitiate our conclusion that
a universal intervention strategy in primary care is unlikely
to be cost-effective. We focused on the effect of interven-
tion on fruit and vegetable consumption but other dietary
changes, such as consumption of fat or fibre, may also be
associated with health outcomes. However, self-reported
dietary change measures, used in many intervention
studies, may have over-estimated the potential effects of
intervention. A previous systematic review [18], found a
larger intervention effect that but this review included
high-risk groups including those with hypertension,
hyperlipidaemia or having close relatives with type 2 dia-
betes or cancer. We also acknowledge that we did not
utilise empirical data for the unit costs of intervention.
We used a low estimate for the unit cost of intervention
and, even with this estimate, the intervention strategy was
found not to be cost-effective. More resource intensive
interventions are likely to be even less cost-effective, as
evidenced by the sensitivity analysis in which a higher
intervention cost was used. Our systematic review [MS re-
submitted to BMC Public Health] provides information
on the resources used in previous intervention studies,
and these interventions were generally considerably more
resource intensive than the one modelled here. We did
not model any social multiplier effects, where the impact
of the intervention delivered to one person might motiv-
ate the individual’s social contacts to change. It is possible
this may have underestimated the benefits of intervention.
We did not set an upper age limit for participants as fruit
and vegetable intake may be beneficial even in old age
[34].We assessed the cost effectiveness of intervention in
selected age groups of population which shows that inter-
vention is more cost effective in older age groups. We ap-
plied a half cycle correction but this had only a small
effect as the perspective of the model, up to 70 years, was
long in relation to the length of the annual cycles. How-
ever, we acknowledge that there are arguments both for
and against the implementation of a half-cycle correction
[35,36]. We included only the health care costs; outcomes
might differ if costs and productivity from a wider per-
spective were to be included. We obtained data from pri-
mary care records and we could not follow patient use of
secondary care resources beyond referral and admission;
this may have underestimated the utilisation of secondary
care. We used the average of all costs over all stages of
disease which may not have represented the actual re-
source utilisation costs as health care resource utili-
sation costs may be higher at the start of illness or at
periods closer to death. Utility estimates were drawn
from a compendium of values, which may not have pro-
vided an entirely accurate assessment for this popula-
tion. We used a cost-effectiveness threshold of £30,000
per QALY as this is a widely accepted level below which
interventions are judged to be cost-effective in the
United Kingdom. However, some policy decisions have
indicated that higher threshold values might sometimes
be accepted in practice [37].
Conclusions
Our findings provide insights into the potential for a
universal strategy of brief intervention in primary care
to promote dietary change. The expected dietary beha-
vioural change from such a strategy is small, but even a
modest increase in consumption of fruit and vegetables,
may increase the number of life years lived free from
physical disease and reduce the duration of time lived
with chronic disease. The present results suggest that,
even when implemented at very low unit cost, it is un-
likely that a universal brief intervention strategy might
have acceptable cost-effectiveness. There may be greater
potential for a targeted strategy but further research is
needed to identify appropriate strategies for targeting
interventions. The main reason for the lack of cost-
effectiveness is the very limited effects from intervention
demonstrated in published intervention studies. There is
therefore considerable scope to develop and implement
more effective behavioural intervention strategies for
dietary change.
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